Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate.
Dexamphetamine (AMPH) is a psychostimulant drug that is used both recreationally and as medication for attention deficit hyperactivity disorder. Preclinical studies have demonstrated that repeated exposure to AMPH can induce damage to nerve terminals of dopamine (DA) neurons. We here assessed the un...
Main Authors: | Anouk Schrantee, Jordi L Tremoleda, Marzena Wylezinska-Arridge, Valentine Bouet, Peter Hesseling, Gideon F Meerhoff, Kora M de Bruin, Jan Koeleman, Thomas Freret, Michel Boulouard, Emilie Desfosses, Laurent Galineau, Alessandro Gozzi, François Dauphin, Willy Gsell, Jan Booij, Paul J Lucassen, Liesbeth Reneman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5328278?pdf=render |
Similar Items
-
Imaging technologies for preclinical models of bone and joint disorders
by: Tremoleda, J, et al.
Published: (2011) -
Piloting a new approach to the treatment of obesity using dexamphetamine
by: Alison Sally Poulton, et al.
Published: (2015-02-01) -
phMRI: methodological considerations for mitigating potential confounding factors
by: Julius H Bourke, et al.
Published: (2015-05-01) -
Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI.
by: Chan, J, et al.
Published: (2014) -
Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients
by: Michelle M. Solleveld, et al.
Published: (2017-01-01)